Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Frank Gary Renshaw"'
Autor:
Anthony J. Bowdler, Frank Gary Renshaw
Publikováno v:
The Complete Spleen ISBN: 9781617370717
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29809da16b1dd60727e645c57f9a5508
https://doi.org/10.1007/978-1-59259-124-4_8
https://doi.org/10.1007/978-1-59259-124-4_8
Autor:
Frank Gary Renshaw, Anthony J. Bowdler
Publikováno v:
The Complete Spleen ISBN: 9781617370717
The high frequency with which deficits in the principal cell lines occur in the blood counts of patients with splenomegaly has indicated a special relationship between the spleen and the composition of the circulating blood. To some, this has suggest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b60955ece7c3b7b66b6371a88cdfaa9
https://doi.org/10.1007/978-1-59259-124-4_7
https://doi.org/10.1007/978-1-59259-124-4_7
Autor:
George R. Blumenschein, Carol Peña, Ramesh K. Ramanathan, Donald A. Richards, Andrea Kelly, Ferry A.L.M. Eskens, Prabhu Rajagopalan, Frank Gary Renshaw, Klaus Mross, Daniel D. Von Hoff
Publikováno v:
Journal of Clinical Oncology. 32:2588-2588
2588 Background: Dual inhibition of the PI3K and MAPK signaling pathways is a promising strategy for optimal anticancer therapy. In this phase 1b trial we determined the maximum tolerated dose (MTD...
Autor:
Isabelle Genvresse, Jennifer Kaplan, Frank Gary Renshaw, Steven R. Alberts, Stefanie Reif, Richard D. Kim, Juneko E. Grilley-Olson
Publikováno v:
Journal of Clinical Oncology. 32:2610-2610
2610 Background: Copanlisib (BAY 80–6946) is a potent and reversible pan-class I PI3K inhibitor with significant activity against PI3K-δ and PI3K-α isoforms. We report the results of an open-label,...